APA (7th ed.) Citation

Yutong Sima, M., Ming Zheng, M., Yan Zhao, P., Siqi Ge, P., Chengyao Liu, M., Ping Wang, B., . . . Luo Zhang, M. Predicting the effectiveness of omalizumab in patients with refractory chronic rhinosinusitis with nasal polyps comorbid with asthma based on inflammatory biomarkers. Elsevier.

Chicago Style (17th ed.) Citation

Yutong Sima, MD, MD Ming Zheng, PhD Yan Zhao, PhD Siqi Ge, MD Chengyao Liu, BS Ping Wang, MD Xiangdong Wang, and MD Luo Zhang. Predicting the Effectiveness of Omalizumab in Patients with Refractory Chronic Rhinosinusitis with Nasal Polyps Comorbid with Asthma Based on Inflammatory Biomarkers. Elsevier.

MLA (9th ed.) Citation

Yutong Sima, MD, et al. Predicting the Effectiveness of Omalizumab in Patients with Refractory Chronic Rhinosinusitis with Nasal Polyps Comorbid with Asthma Based on Inflammatory Biomarkers. Elsevier.